EMS Ltd
EMSLIMITEDEMS Ltd's three tracks disagree. Price, valuation and the earnings engine each tell a different story — the next quarter or two settles it.
Biggest watch item: the P/E sits at the 99th percentile of its own range — the multiple has already done part of the work.
The price is building a base (4 weeks in) while the P/E sits at the 99th percentile of its own 3-year range. Underneath, the last four quarters read deteriorating — profit −60.5% year on year, and −22% of the last 3 years' profit arrived as cash. What settles it: the next one or two quarters of delivery.
Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.
EMS Ltd trades at ₹383, building a base and 4 weeks into that stage. That is −4.0% against its own 200-day average. It sits at 40% of a 52-week range of ₹271 to ₹550. On relative strength it is currently behind the NIFTY 500 on a trailing-13-week view (1 week and counting).
Today the stock is building a base — week 4 of stage 1, confirmed. At ₹383 it trades −4.0% versus its 200-day average and sits at 40% of its 52-week range (₹271–₹550).
Against the market, two honest reads. Cumulative: over the last 3.0 years the stock moved +43% while the NIFTY 500 moved +32% — ahead of the index over the full window. Recent form: on a trailing-13-week view the stock is currently behind (1 week and counting; last ahead the week of 2026-09-04) — the ribbon below is that same metric, week by week.
What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.
Valuation P/E is the price of ₹1 of annual profit: how many rupees the market pays for each rupee the company earns in a year.
EMS Ltd trades at 31.2× P/E, about the priciest it has ever traded. Its long-run median P/E is 19.3×, measured across 3.0 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.
Today's P/E of 31.2× is about the priciest it has ever traded, against a long-run median of 19.3× measured over 3.0 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.
Why the multiple sits where it does: over the past year annual EPS moved −50.7% against a −31.2% price move — the price outran earnings, pushing the multiple UP its own range.
The price move, decomposed: over 3y, of the +12.7%/yr price move, ~−18.7%/yr came from earnings growth and ~+31.4 pp from the multiple (expanding). The split is the honest approximate (price return minus earnings growth); it makes the rally itself visible instead of hiding it behind the percentile.
Put together: the multiple is full against its own past, so the story rests on the earnings line underneath it, not the multiple.
What the price assumes This reading works the multiple backwards. It asks one question: what yearly rate of profit growth is a buyer at the market price already paying for? The number is the growth rate that makes eleven years of profit — six years growing, then five fading — add up to that day's market price, once each year is discounted at 11% a year.
Solved at its 13 June 2026 price, EMS Ltd was paying for profit growth of about 11.1% a year. Profit itself has compounded 4.0% a year over the past 6 years. Today the market pays 31.2× P/E, the 99th percentile of its own 3-year range.
What the two numbers say together. The multiple is full against its own past, and the growth the price is paying for is far above what this company has actually delivered.
How to hold this number: it is a reading of one day's price, taken on 13 June 2026, not a running figure — every other number on this page, the multiple included, is read off the live quote as of 11 September 2026. A higher price is paying for more growth and a lower price for less, so it moves whenever the price does, and this page does not restate it between measurements.
Stage: Deteriorating Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).
EMS Ltd reads as deteriorating on its fundamental arc. Deteriorating — revenue and profit growth are shrinking (revenue growth −34.1% latest against +28.1% at its 12-quarter best), ROCE slipping at 12.6%. The read is built from 11 quarters across 3 curves, on partial evidence.
🚨 Why it matters: falling curves mean every cheap-looking ratio below needs a discount for direction.
A partial read: at least one curve is short, or the returns curve is not the computed quarterly series — hold the stage word a little more loosely.
| 1yr | 3yr | 5yr | 10yr | |
|---|---|---|---|---|
| Revenue | −24.8% | +10.8% | +17.2% | — |
| Profit | −50.5% | −5.8% | +4.8% | — |
| EPS | −50.7% | −10.7% | −23.2% | — |
| Share price | −31.2% | +12.7% | — | — |
4-Factor Sector Score
29.9/100 — rank 6 of 8 in Infra - Engineering - General · 94% evidence confidence
EMS Ltd scores 29.9 out of 100 against the 8 companies it is compared with in Infra - Engineering - General, ranking 6. Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
The four contributions add to the total exactly: 6.5 + 13.1 + 4.3 + 6 = 29.9. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.
What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.
Revenue Revenue is the top line: everything the company billed its customers in the period.
EMS Ltd reported ₹157 Cr of revenue in the Jun 26 quarter, −34.3% year on year. Over 6 years it has compounded at 14.4% a year. The last full year, FY26, came in at ₹731 Cr. The last four reported quarters add to ₹650 Cr.
FY26 revenue came in at ₹731 Cr (−24.8% on the year), capping 6 years at 14.4% compound. The latest quarter (Jun 26) printed ₹157 Cr, −34.3% year on year.
Pace check: the last four quarters averaged −33.5% growth against the decade's 14.4% — the current year is running slower than its own long-run rate.
Acceleration check: trailing-twelve-month revenue grew −34.1% over the last 4 quarters against −13.2%/yr over the last 8 — rolling over; TTM profit −63.4% vs −36.0%/yr — rolling over.
Operating margin Operating margin is what is left of every ₹100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.
EMS Ltd's operating margin is 17.0% in the Jun 26 quarter, −6.0 percentage points against the same quarter a year ago. Across 7 fiscal years the operating margin has ranged 20.0% to 31.0%. The current quarter is running below every full year in that window.
The latest quarter's operating margin is 17.0%, −6.0 pp against the same quarter a year ago. Across 7 fiscal years the operating margin has ranged 20.0%–31.0%.
🚨 Why the margin moved: operating margin went −6.1 pp year on year while gross margin went +2.9 pp — the loss came mostly below the gross line: operating leverage, with costs spread over a bigger revenue base.
Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.
EMS Ltd earned ₹15.0 Cr of net profit in the Jun 26 quarter, −60.5% year on year. Full-year FY26 profit was ₹91.0 Cr. The 6-year compound rate is 4.0%. That is 9.6% of the quarter's revenue. The same quarter a year earlier earned ₹38.0 Cr.
Jun 26 profit was ₹15.0 Cr, −60.5% year on year. On the full year, FY26 printed ₹91.0 Cr (−50.5%), and the 6-year compound rate is 4.0%.
🚨 Why profit moved: revenue contributed −34.3% and the margin −6.0 pp — the quarter was revenue-led despite a thinner margin.
Pace comparison, last four quarters: profit −63.6% vs revenue −33.5%. Profit is growing slower than sales — costs are eating the growth before it reaches the bottom line.
Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.
Over the last 3 fiscal years −22% of EMS Ltd's reported profit arrived as operating cash — a gap worth watching. In FY26 that was ₹−15.0 Cr of operating cash against ₹91.0 Cr of profit. After ₹74.0 Cr of capital spending, ₹−89.0 Cr was left as free cash. Cash resolution here is annual, because quarterly cash statements are not published.
FY26: operating cash of ₹−15.0 Cr against reported profit of ₹91.0 Cr, leaving free cash of ₹−89.0 Cr after ₹74.0 Cr of capital spending. Across the last 3 fiscal years the conversion rate is −22% of profit.
Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.
🚨 Why conversion sits at −22%: the cash cycle stretched 230 days between FY21 and FY26 — more of each rupee of profit waits inside the cycle before arriving. Less than 70% of profit arriving as cash is the thing to watch on this page.
Router verdict: conversion is below par and the cash cycle has stretched 230 days — the next section's job is to find where the cash is stuck.
Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).
EMS Ltd's cash conversion cycle runs 333 days in FY26, up from 103 days in FY21. Capital spending ran ₹129 Cr over the last 3 years. At FY26 sales of ₹731 Cr each day of that cycle holds about ₹2.0 Cr, so roughly ₹667 Cr sits inside the business at any moment.
FY26: debtors at 193 days, inventory at 163 days — roughly 5.4 months of stock waiting to sell; that is where the cash sits while it waits — for a full cycle of 333 days, looser than FY21's 103.
The full loop: cash goes out to suppliers and production on day 0; stock waits 163 days to sell; customers pay about 193 days after that; and suppliers themselves are paid at 24 days — netting out to the 333-day cycle.
In money terms: at FY26 sales of ₹731 Cr, each day of the cycle holds about ₹2.0 Cr — so the 333-day loop keeps roughly ₹667 Cr sitting inside the business at any moment.
On the investment side: capital spending of ₹129 Cr over the last 3 fiscal years against ₹27.0 Cr of depreciation — the company is building well ahead of wear-and-tear. Capital work-in-progress stands at ₹37.0 Cr (FY26) — capacity paid for but not yet earning.
The synthesis: the working-capital loop is the cash sink the router flagged — watch the cycle, not the P&L.
Return on capital Return on capital employed (ROCE) is the profit the whole business earns on all the money in it — equity and debt together. It is the single best test of whether growth creates value or just size.
EMS Ltd earns a ROCE of 13% in FY26. Return on invested capital clears the cost of that capital by −5.9 percentage points, so growth here is not yet paying for the capital it uses. The wiring behind it is 12.4% net margin on 0.55× asset turns.
FY26 ROCE is 13%.
🚨 Why the return is what it is — the wiring (FY26): 12.4% net margin × 0.55× asset turns × 1.26× balance-sheet leverage ≈ 8.6% on equity. Margin does its share; leverage is modest — this is an earned return, not a borrowed one.
The capstone test — ROIC − WACC: 6.1% − 12.0% = a −5.9 pp spread. The 12.0% is a standing assumption for the cost of capital in India, not a per-stock estimate — read the sign and the size of the spread, not the decimals. Negative — growth at these returns destroys value until the returns recover.
Debt Debt-to-equity says how much of the business is funded by borrowings. Low is the safe corner; the trend matters as much as the level.
EMS Ltd carries total debt of ₹154 Cr against shareholder equity of ₹1,058 Cr as of Mar 26, a debt-to-equity of 0.15 — effectively unlevered. On the annual view that ratio went from 0.09 in FY23 to 0.15 in FY26. The returns elsewhere on this page are therefore earned rather than borrowed.
Mar 26: total debt of ₹154 Cr against shareholder equity of ₹1,058 Cr — a debt-to-equity of 0.15. On the annual view, debt-to-equity went from 0.09 (FY23) to 0.15 (FY26). The returns on this page are earned, not borrowed.
Ownership Who owns the stock, quarter by quarter: promoters (the controlling owners), foreign and domestic institutions, and the public. Steady accumulation by people close to the numbers is a signal; a quiet register is also an answer.
Domestic institutions cut 1.5 points of EMS Ltd over 8 quarters, the biggest move on the register. That takes domestic institutions to 0.1% of the company. Foreign institutions moved −0.7 points over the same window, to 0.1%. The register is read on the four disclosed classes only; nothing is inferred between filings.
The register over the last two years — Domestic institutions: −1.5 points over 8 quarters to 0.1%; Foreign institutions: −0.7 points over 8 quarters to 0.1%; Promoters: +0.0 points over 8 quarters to 69.7%.
🚨 Why the register moved: domestic institutions drove it (−1.5 points), alongside foreign institutions (−0.7 points) — distribution into the market’s bid.
Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.
EMS Ltd: the Z-score is not available for this stock, so we say so rather than invent one. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure. The debt, cash-flow and return sections above carry the balance-sheet evidence this page does hold, and each of them states its own reporting date.
The safety line in one sentence: the Z-score is not available for this stock, so we say so rather than invent one.
| Company | Score | Price stage | Growth & earnings/35 | Capital efficiency/25 | Valuation/20 | Relative strength/20 |
|---|---|---|---|---|---|---|
| 1Engineers India LtdENGINERSIN | 84.9/100Sector-leading setup100% evidence | TURNING | 29.5/35 Revenue 16.3% · PAT 41.5% · OPM change 7 pp 100% evidence | 19.6/25 ROCE 30.4% · OPM 15% 100% evidence | 15.8/20 P/E 19.3× · PEG 1.07 100% evidence | 20.0/20 RS sector 30% · RS bench 25.5% · 1Y 33.7%7 of 12 weeks ahead 100% evidence |
| Exact sum: 29.5 + 19.6 + 15.8 + 20 = 84.9 · Decision use: Confirmed research leader: earnings, capital efficiency and relative strength agree. Move to management, catalyst and risk diligence. | ||||||
| 2Axtel Industries LtdAXTEL | 72.9/100Favorable setup76% evidence | 32.5/35 Revenue 42.1% · PAT 97.3% · OPM change 2.3 pp 95% evidence | 16.5/25 ROCE 30% · OPM 7.8% 76% evidence | 9.8/20 P/E 22.8× · PEG — 50% evidence | 14.1/20 RS sector 4.3% · RS bench 2% · 1Y -3.8%1 of 12 weeks ahead 70% evidence | |
| Exact sum: 32.5 + 16.5 + 9.8 + 14.1 = 72.9 · Decision use: Confirmed research leader: earnings, capital efficiency and relative strength agree. Move to management, catalyst and risk diligence. | ||||||
| 3Bondada Engineering Ltd543971 | 58.0/100Mixed-positive evidence65% evidence | BASING | 18.3/35 Revenue — · PAT — · OPM change -1 pp 45% evidence | 19.6/25 ROCE 39.4% · OPM 11% 76% evidence | 14.8/20 P/E 14.4× · PEG — 50% evidence | 5.3/20 RS sector -12.6% · RS bench -15.9% · 1Y -27.6%2 of 12 weeks ahead 100% evidence |
| Exact sum: 18.3 + 19.6 + 14.8 + 5.3 = 58 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 4ISGEC Heavy Engineering LtdISGEC | 44.4/100Mixed-negative evidence100% evidence | BASING | 19.9/35 Revenue 19.5% · PAT 5.7% · OPM change -3 pp 100% evidence | 11.7/25 ROCE 10.8% · OPM 6% 100% evidence | 6.5/20 P/E 22.4× · PEG 1.64 100% evidence | 6.3/20 RS sector -5.7% · RS bench -9.1% · 1Y -21.1%0 of 12 weeks ahead 100% evidence |
| Exact sum: 19.9 + 11.7 + 6.5 + 6.3 = 44.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 5Ircon International LtdIRCON | 35.9/100Mixed-negative evidence100% evidence | BASING | 12.7/35 Revenue -9.9% · PAT -22.2% · OPM change -1 pp 100% evidence | 9.3/25 ROCE 9.3% · OPM 10% 100% evidence | 12.2/20 P/E 20.3× · PEG 1.13 100% evidence | 1.7/20 RS sector -19.2% · RS bench -22.1% · 1Y -33%0 of 12 weeks ahead 100% evidence |
| Exact sum: 12.7 + 9.3 + 12.2 + 1.7 = 35.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 6EMS Ltdthis pageEMSLIMITED | 29.9/100Adverse evidence94% evidence | BREAKING OUT | 6.5/35 Revenue -34.1% · PAT -63.4% · OPM change -6 pp 100% evidence | 13.1/25 ROCE 12.8% · OPM 17% 100% evidence | 4.3/20 P/E 31.2× · PEG 2.09 100% evidence | 6.0/20 RS sector -35.9% · RS bench -1.4% · 1Y -33.4%10 of 10 weeks ahead 70% evidence |
| Exact sum: 6.5 + 13.1 + 4.3 + 6 = 29.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 7Artson LtdARTSON | 29.3/100Adverse evidence66% evidence | 7.0/35 Revenue 8.7% · PAT -80% · OPM change -2.9 pp 95% evidence | 4.8/25 ROCE -14.6% · OPM 4.5% 76% evidence | 10.0/20 P/E — · PEG — 0% evidence | 7.5/20 RS sector -7.5% · RS bench -4.4% · 1Y -7.6%0 of 12 weeks ahead 70% evidence | |
| Exact sum: 7 + 4.8 + 10 + 7.5 = 29.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 8BGR Energy Systems LtdBGRENERGY | 27.3/100Adverse evidence63% evidence | ASLEEP | 5.1/35 Revenue -38.3% · PAT -10.9% · OPM change -529 pp 71% evidence | 1.0/25 ROCE -26.9% · OPM -648% 95% evidence | 10.0/20 P/E — · PEG — 0% evidence | 11.2/20 RS sector 28.2% · RS bench -26.2% · 1Y 11%1 of 10 weeks ahead 70% evidence |
| Exact sum: 5.1 + 1 + 10 + 11.2 = 27.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led NIFTY 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.
Frequently asked questions
What is EMS Ltd's share price today?
EMS Ltd trades at ₹383, −31.2% over the past year. The company is valued at ₹2,127 Cr. The stock sits at 40% of its 52-week range of ₹271–₹550, −4.0% versus its 200-day average. On the tape, the price is building a base, 4 weeks in. — as of 11 September 2026.
What were EMS Ltd's latest quarterly results?
EMS Ltd reported revenue of ₹157 Cr and net profit of ₹15.0 Cr for the Jun 26 quarter. Revenue fell 34.3% and profit fell 60.5% year on year. Earnings per share were ₹2.79. The operating margin was 17.0%, 6.0 pp lower than a year earlier. — as of 11 September 2026.
What is EMS Ltd's revenue?
EMS Ltd reported revenue of ₹157 Cr in the Jun 26 quarter, −34.3% year on year. For the full FY26 fiscal year, revenue was ₹731 Cr (−24.8%). Over the last 6 years revenue compounded at 14.4% a year. — as of 11 September 2026.
What is EMS Ltd's profit?
EMS Ltd earned ₹15.0 Cr of net profit in the Jun 26 quarter, −60.5% year on year. Full-year FY26 profit was ₹91.0 Cr. The operating margin ran 17.0% in the latest quarter. — as of 11 September 2026.
What is EMS Ltd's market cap?
EMS Ltd's market capitalisation is ₹2,127 Cr at a share price of ₹383. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 11 September 2026.
What is EMS Ltd's P/E ratio?
EMS Ltd trades at a P/E of 31.2×, at the 99th percentile of its own 3-year range, against a long-run median of 19.3×. This is a comparison with the stock's own history, not a value call — as of 11 September 2026.
Does EMS Ltd pay a dividend?
Yes — EMS Ltd's dividend payout was 9% of profit in FY26, and it recorded a payout in 3 of its last 7 reported fiscal years. This page holds the payout ratio, not a per-share amount. — as of 11 September 2026.
Is EMS Ltd overvalued?
On its own history, EMS Ltd looks expensive: its P/E of 31.2× sits at the 99th percentile of its 3-year range (long-run median 19.3×). That is a percentile read against the stock's own past, not a price opinion or a direction call. — as of 11 September 2026.
Is EMS Ltd growing?
Not right now — EMS Ltd's latest numbers are shrinking: latest-quarter revenue −34.3% year on year, profit −60.5%, and the margin −6.0 pp at 17.0%. The 6-year compound rates are 14.4% (revenue) and 4.0% (profit). The earnings engine currently reads: deteriorating — as of 11 September 2026.
How is EMS Ltd performing?
EMS Ltd is building a base, 4 weeks in. Its latest quarter's revenue fell 34.3% and profit fell 60.5% year on year. Against the NIFTY 500 it has been behind on a trailing-13-week view for 1 week. This describes what the data did, not a rating. — as of 11 September 2026.
What stage is EMS Ltd in?
Deteriorating — revenue and profit growth are shrinking (revenue growth −34.1% latest against +28.1% at its 12-quarter best), ROCE slipping at 12.6%. The read comes from the last 12 quarters of growth (revenue growth −34.1% latest, profit growth −63.4% latest) plus the ROCE curve, classified by deterministic rules — a trajectory read, not a buy or sell call — as of 11 September 2026.
Is EMS Ltd in an uptrend?
No — the price is building a base (week 4 of stage 1), trading −4.0% versus its 200-day average and at 40% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 11 September 2026.
Is EMS Ltd beating the market?
Not lately — on a trailing-13-week view EMS Ltd is currently behind the NIFTY 500 (1 week and counting; last ahead the week of 2026-09-04), the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 3.0 years the stock moved +43% against the NIFTY 500's +32% — ahead of the index over the full window. — as of 11 September 2026.
Will EMS Ltd's share price go up?
This page publishes no price forecast for EMS Ltd. What it measures instead: the share price is ₹383, the price is building a base 4 weeks in. Its P/E of 31.2× sits at the 99th percentile of its own 3-year range. Direction is not something this site claims to know. — as of 11 September 2026.
Who owns EMS Ltd?
Promoters hold 69.7% of EMS Ltd, foreign institutions 0.1%, domestic institutions 0.1% and the public 30.1% (latest quarter). The biggest move on the register over the last two years: Domestic institutions cut 1.5 points over 8 quarters. — as of 11 September 2026.
Does EMS Ltd have too much debt?
No — EMS Ltd's debt-to-equity is 0.15, and operating profit covers the interest bill 9×. FY26 borrowings were ₹154 Cr against equity of ₹1,056 Cr. The returns on this page are earned, not borrowed — as of 11 September 2026.
What is EMS Ltd's capex?
EMS Ltd spent ₹129 Cr on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY26 alone that was ₹74.0 Cr, with ₹37.0 Cr in capital work-in-progress — capacity paid for but not yet earning. — as of 11 September 2026.
What is EMS Ltd's cash flow?
EMS Ltd consumed ₹15.0 Cr of operating cash in FY26 — cash flowed out rather than in (free cash flow: ₹−89.0 Cr). Operating cash was negative while the company reported a profit of ₹91.0 Cr. Cash-flow resolution for India is annual. — as of 11 September 2026.
Is EMS Ltd's profit real cash?
No — operating cash was negative over the last 3 fiscal years: EMS Ltd consumed cash while reporting profit. In FY26, operating cash was ₹−15.0 Cr against reported profit of ₹91.0 Cr. Cash-flow resolution is annual — as of 11 September 2026.
Where is EMS Ltd in its business cycle?
EMS Ltd's FY26 operating margin was 20.0%, against a 7-year band of 20.0%–31.0%: the low end of its own band, which is where recoveries start when they come. The latest quarter ran 17.0%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 11 September 2026.
What growth does EMS Ltd's price assume?
At its price on 13 June 2026, EMS Ltd was priced for profit growth of about 11.1% a year. Profit itself has compounded 4.0% a year over the past 6 years. The figure reads the multiple backwards: the growth a buyer at that price was already paying for. — as of 11 September 2026.
What could break the EMS Ltd story?
Biggest watch item: the P/E sits at the 99th percentile of its own range — the multiple has already done part of the work. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 11 September 2026.
Is EMS Ltd a stock worth studying right now?
This is not investment advice. The machine read: EMS Ltd's three tracks disagree. Price, valuation and the earnings engine each tell a different story — the next quarter or two settles it. The sharpest open question: the next one or two quarters of delivery. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 11 September 2026.
Not SEBI Registered !! Not Investment advice !!